TÜV SÜD has signed a Memorandum of Understanding (MoU) with the NUS Centre for Additive Manufacturing (AM.NUS) at the National University of Singapore (NUS), to promote R&D activities in the area of 3D printed biomedical implants for clinical trials.
AM.NUS seeks to bring innovative products to the field of healthcare that will improve patient outcomes and change lives for the better. The centre strives to explore a whole new dimension in Medical Additive Manufacturing, applying innovative 3D printing technology for personalised patient treatments.
TÜV SÜD as a premier third-party quality assurance organisation, works closely with the industry in providing them with the right expertise in the areas of certification, inspection and auditing. With its suite of service offerings, the company has partnered AM.NUS to provide Medical AM Certification ISO 13485 and certification services and other quality assurance requirements. The centre will be the first in Singapore to attain both the AM Design and Development and ISO 13485 certification. These certifications apply to the centre’s facility located at the NUS Faculty of Engineering, which will fabricate 3D printed metal implants for clinical trials.
At the signing ceremony, Richard Hong, CEO, TÜV SÜD ASEAN, said, “Additive Manufacturing is ushering in transformation in the production of medical devices as the technology is enabling businesses to push boundaries. We are excited to work with AM.NUS, as this collaboration makes us the first company to certify the first AM Design and Development that can print 3D printed metal implants for clinical trials.”
“Additive Manufacturing technology can be considered as a great opportunity to provide easy access to healthcare in developing countries. It is a crucial step towards engineering patient-specific medical products. Thus, it is imperative to meet the global standards while developing these products. Partnership with TÜV SÜD is of strategic importance since it will help us achieve global standards while we build and strengthen our base in the region,” said Professor Jerry Fuh Ying-Hsi, Director of AM.NUS, who is also from the Department of Mechanical Engineering at the NUS Faculty of Engineering.
The MoU between AM.NUS and TÜV SÜD will bring together both companies in their concerted efforts to define new frontiers in R&D in the space of 3D printing of medical implants.
Check out these articles:
WANT MORE INSIDER NEWS? SUBSCRIBE TO OUR DIGITAL MAGAZINE NOW!